🇺🇸 FDA
Patent

US 10450572

Androgen receptor variant inhibitors and methods of using

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10450572 (Androgen receptor variant inhibitors and methods of using) held by Regents of the University of Minnesota expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P35/00